Sysmex Europe

Sysmex Donates ¥30 Million to Kobe City Support Fund for Medical Professionals to Support COVID-19 Countermeasures

Our thoughts and prayers are with the families of those who have perished as a result of the novel coronavirus (COVID-19), and we offer our heartfelt sympathy to the patients currently suffering from this disease. We are truly grateful for the efforts of the medical community and all others who are working on the front lines to stop this pandemic from spreading. Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has decided to donate ¥30 million to the Kobe City Support Fund for Medical Professionals to support measures for countering COVID-19.

Sysmex was the first to obtain marketing approval in Japan for a COVID-19 test kit (RT-PCR method). We have taken the lead in working with the city of Kobe through an industry–government alliance to build  and  operate  a  system  to  serve  as  a  role  model  for strengthening  PCR  testing.  In  various countries around the world, the Sysmex Group is also donating supplies to medical professionals.

Kobe City Support Fund for Medical Professionals expresses gratitude to, and supports the activities of, the medical professionals who are working around the clock on the front lines to treat and prevent the  spread  of  COVID-19.  Contributions to  this  fund are channeled  to  medical institutions  in  Kobe. Sysmex  supports  the  goal  of  this  fund,  which  is  to  improve  the  working  conditions  of  medical professionals during this crisis.

Sysmex believes its mission is to support the medical professionals who are on the frontline of the fight to prevent the spread of COVID-19. We are ensuring the continuity of clinical testing that these professionals perform daily in various healthcare settings around the world, to overcome this difficult situation together. To this end, we are trying our utmost to ensure a stable supply of products and services. In addition, to successfully combat theCOVID-19 pandemic and bring things under control as  soon  as  possible,  we  are  working  to  develop  new  diagnostic  technologies,  prevent  the  further spread of infection, and ensure our employees’ safety.

Back to overview
Copyright © Sysmex Europe SE. All rights reserved.
Customize your experience

We use cookies to enable you to optimally use our Website and to improve our communication with you. We shall take your selection into account and use only the data for which you give us your consent.

* May lead to restrictions in content and in the user experience
Detail about cookies
Essential cookies
These cookies help to make our website usable by enabling basic features such as page navigation and access to secure areas of our website. Our website cannot function properly without these cookies.
Statistics cookies
By collecting information anonymously, these cookies help us to understand how visitors interact with our website. This information enables us to continually improve our platform.
Marketing cookies
are used to track visitors on websites. The intention is to show advertisements that are relevant and appealing to the individual user and are, therefore, valuable to publishers and third-party advertisers.